Eylea HD 8 MG/0.07 ML vial 0.07ML
Ended Awarded Last action
- Contract number
- SPE2DR26FBPNQ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,132
Award facts
- Contract value 100% obligated
- $12,132.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $12,132.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EYLEA HD 8 mg/0.07 ml vials. The delivery order was issued on December 17, 2025, with an ultimate completion date of January 9, 2026, and carries no set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. Performance will take place at the vendor's Park Ridge facility.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (SPE2DR) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $499.9 billion acquisition strategy established to support Department of Defense medical supply requirements worldwide. The PPV-G GEN V represents a strategic initiative to consolidate pharmaceutical sourcing across the military healthcare system, with DMS Pharmaceutical Group positioned as a regional prime vendor contractor authorized to supply branded and generic prescription medications, biologics, and medical consumables to support recurring medical needs at military healthcare facilities globally. The contractor's demonstrated performance on numerous prior delivery orders across diverse pharmaceutical categories validates its capability to fulfill specialized federal military medical requirements.
Quick answers
Who was awarded contract SPE2DR26FBPNQ?
SPE2DR26FBPNQ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 17, 2025.
How much is contract SPE2DR26FBPNQ worth?
The government has obligated $12,132 on SPE2DR26FBPNQ.
Is contract SPE2DR26FBPNQ an order under another contract?
Yes. SPE2DR26FBPNQ is a delivery order under SPE2DR25D9309, an indefinite delivery contract.
Was contract SPE2DR26FBPNQ competed?
The extent of competition for SPE2DR26FBPNQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award